Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T22:38:34.901Z.
Calculation as of: 2026-10-06T22:38:34.901Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: eb6c183c54b52a3f5be7b88cd35f52a8db6123751fb387d2cb2c86d403628cdc
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$416.27M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$418.95M
Operating Cash Flow Yield
N/A
TTM Avg
1.96%
3Y Avg
1.96%
5Y Avg
1.96%
Market Cap
$419.87M
Operating Cash Flow Yield
N/A
TTM Avg
4.45%
3Y Avg
4.45%
5Y Avg
4.45%
Market Cap
$411.21M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$411.00M
Operating Cash Flow Yield
N/A
TTM Avg
2.44%
3Y Avg
2.44%
5Y Avg
2.42%
Market Cap
$422.72M
Operating Cash Flow Yield
N/A
TTM Avg
0.69%
3Y Avg
0.69%
5Y Avg
0.69%
Market Cap
$422.86M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$424.10M
Operating Cash Flow Yield
5.20%
TTM Avg
5.09%
3Y Avg
4.22%
5Y Avg
4.07%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rezolute, Inc. (RZLT) | $415.98M | N/A | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | N/A | N/A | N/A | N/A |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | N/A | 1.96% | 1.96% | 1.96% |
| Prothena Corporation plc (PRTA)vs › | $419.87M | N/A | 4.45% | 4.45% | 4.45% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | N/A | N/A | N/A | N/A |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.00M | N/A | 2.44% | 2.44% | 2.42% |
| Tilray Brands, Inc. (TLRY)vs › | $422.72M | N/A | 0.69% | 0.69% | 0.69% |
| Tectonic Therapeutic, Inc. (TECX)vs › | $422.86M | N/A | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | 5.20% | 5.09% | 4.22% | 4.07% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
